BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 31435126)

  • 1. Trends in Percutaneous Thermal Ablation Therapies in the Treatment of T1a Renal Cell Carcinomas Rather than Partial Nephrectomy/Radical Nephrectomy.
    Shakeri S; Raman SS
    Semin Intervent Radiol; 2019 Aug; 36(3):183-193. PubMed ID: 31435126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Percutaneous Thermal Ablation for Treatment of T1a Renal Cell Carcinomas.
    Shakeri S; Raman SS
    Radiol Clin North Am; 2020 Sep; 58(5):981-993. PubMed ID: 32792128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thermal Ablation of T1a Renal Cell Carcinoma: The Clinical Evidence.
    Young S; Golzarian J; Anderson JK
    Semin Intervent Radiol; 2019 Dec; 36(5):367-373. PubMed ID: 31798209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative Outcome of Computed Tomography-guided Percutaneous Radiofrequency Ablation, Partial Nephrectomy or Radical Nephrectomy in the Treatment of Stage T1 Renal Cell Carcinoma.
    Cooper CJ; Teleb M; Dwivedi A; Rangel G; Sanchez LA; Laks S; Akle N; Nahleh Z
    Rare Tumors; 2015 Feb; 7(1):5583. PubMed ID: 25918603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cryoablation vs radiofrequency ablation for the treatment of renal cell carcinoma: a meta-analysis of case series studies.
    El Dib R; Touma NJ; Kapoor A
    BJU Int; 2012 Aug; 110(4):510-6. PubMed ID: 22304329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiofrequency Ablation, Cryoablation, and Microwave Ablation for T1a Renal Cell Carcinoma: A Comparative Evaluation of Therapeutic and Renal Function Outcomes.
    Zhou W; Herwald SE; McCarthy C; Uppot RN; Arellano RS
    J Vasc Interv Radiol; 2019 Jul; 30(7):1035-1042. PubMed ID: 30956075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percutaneous cryoablation of solitary sporadic renal cell carcinomas.
    Schmit GD; Thompson RH; Kurup AN; Weisbrod AJ; Carter RE; Callstrom MR; Atwell TD
    BJU Int; 2012 Dec; 110(11 Pt B):E526-31. PubMed ID: 22584010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A critical analysis of the actual role of minimally invasive surgery and active surveillance for kidney cancer.
    Heuer R; Gill IS; Guazzoni G; Kirkali Z; Marberger M; Richie JP; de la Rosette JJ
    Eur Urol; 2010 Feb; 57(2):223-32. PubMed ID: 19853989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous image-guided cryoablation of small renal masses.
    Patel N; King AJ; Breen DJ
    Abdom Radiol (NY); 2016 Apr; 41(4):754-66. PubMed ID: 26915090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can ablation win against partial nephrectomy and become first line therapy in cT1a renal tumours?
    Sandbergen L; Guven S; Laguna MP
    Curr Opin Urol; 2019 Jan; 29(1):70-77. PubMed ID: 30308573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous ablation of the small renal mass-techniques and outcomes.
    Gunn AJ; Gervais DA
    Semin Intervent Radiol; 2014 Mar; 31(1):33-41. PubMed ID: 24596438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical T1a Renal Cell Carcinoma, Not Always a Harmless Disease-A National Register Study.
    Almdalal T; Sundqvist P; Harmenberg U; Hellström M; Lindskog M; Lindblad P; Lundstam S; Ljungberg B
    Eur Urol Open Sci; 2022 May; 39():22-28. PubMed ID: 35528783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiofrequency ablation versus partial nephrectomy in patients with solitary clinical T1a renal cell carcinoma: comparable oncologic outcomes at a minimum of 5 years of follow-up.
    Olweny EO; Park SK; Tan YK; Best SL; Trimmer C; Cadeddu JA
    Eur Urol; 2012 Jun; 61(6):1156-61. PubMed ID: 22257424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Active surveillance of small renal masses offers short-term oncological efficacy equivalent to radical and partial nephrectomy.
    Patel N; Cranston D; Akhtar MZ; George C; Jones A; Leiblich A; Protheroe A; Sullivan M
    BJU Int; 2012 Nov; 110(9):1270-5. PubMed ID: 22564495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on ablative therapies of renal tumors.
    D'Andrea D; Shariat SF; Klatte T
    Curr Opin Urol; 2016 Sep; 26(5):410-6. PubMed ID: 27214581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modern Management of Localized Renal Cell Carcinoma- Is Ablation Part of the Equation?
    Leopold Z; Passarelli R; Mikhail M; Tabakin A; Chua K; Ennis RD; Nosher J; Singer EA
    J Kidney Cancer VHL; 2022; 9(3):5-23. PubMed ID: 36060450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ablative therapy of small renal masses].
    Kriegmair MC; Wagener N; Diehl SJ; Rathmann N
    Urologe A; 2018 Mar; 57(3):285-294. PubMed ID: 29396626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percutaneous microwave ablation of T1a and T1b renal cell carcinoma: short-term efficacy and complications with emphasis on tumor complexity and single session treatment.
    Wells SA; Wheeler KM; Mithqal A; Patel MS; Brace CL; Schenkman NS
    Abdom Radiol (NY); 2016 Jun; 41(6):1203-11. PubMed ID: 27167230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effectiveness, costs and trends in treatment of small renal masses from 2005 to 2007.
    Kowalczyk KJ; Choueiri TK; Hevelone ND; Trinh QD; Lipsitz SR; Nguyen PL; Lynch JH; Hu JC
    BJU Int; 2013 Aug; 112(4):E273-80. PubMed ID: 23452093
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.